Copptech Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 17

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $9.4M

  • Investors
  • 5

Copptech General Information

Description

Developer of antimicrobial technology and ingredients designed to eliminate viruses, bacteria, and fungi from existing manufacturing processes. The company's ingredients eliminate and inhibit the reproduction of pathogenic microorganisms in contact with any surface, thus creating a protective shield between the source of infection and people, enabling clients to incorporate antibacterial protection throughout the day.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 45 Gresham Street
  • London EC2V 7BG
  • England, United Kingdom
Primary Industry
Multi-line Chemicals
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 45 Gresham Street
  • London EC2V 7BG
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Copptech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series B) 30-Aug-2022 $9.4M Completed Generating Revenue
2. Later Stage VC 30-Jul-2021 Completed Generating Revenue
1. Early Stage VC 01-Apr-2018 $3.5M $3.5M Completed Generating Revenue
To view Copptech’s complete valuation and funding history, request access »

Copptech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
B-1 Ordinary
B-1 Ordinary
To view Copptech’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Copptech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of antimicrobial technology and ingredients designed to eliminate viruses, bacteria, and fungi from existing m
Multi-line Chemicals
London, United Kingdom
17 As of 2025

Coventry, United Kingdom
 

Huntersville, NC
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Copptech Competitors (5)

One of Copptech’s 5 competitors is BioCote, a Formerly VC-backed company based in Coventry, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BioCote Formerly VC-backed Coventry, United Kingdom
Microban International Formerly PE-Backed Huntersville, NC
Sanitized Corporation Burgdorf, Switzerland
HeiQ Materials Formerly VC-backed Schlieren, Switzerland
Polygiene Group Corporation Malmo, Sweden
You’re viewing 5 of 5 competitors. Get the full list »

Copptech Patents

Copptech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220047626-A1 Composition of a spray formula to control mastitis in bovines Inactive 18-Dec-2018
CA-2922748-A1 Biocidal resin composition including one or a plurality of resins selected from mf, uf, pf, muf and phenolic resins; and more than one soluble copper salt Active 03-Oct-2013
CA-2922748-C Biocidal resin composition including one or a plurality of resins selected from mf, uf, pf, muf and phenolic resins; and more than one soluble copper salt Active 03-Oct-2013
EP-3053588-A1 Biocidal resin composition including one or a plurality of resins selected from mf, uf, pf, muf and phenolic resins; and more than one soluble copper salt Inactive 03-Oct-2013
EP-3053588-A4 Biocidal resin composition including one or a plurality of resins selected from mf, uf, pf, muf and phenolic resins; and more than one soluble copper salt Inactive 03-Oct-2013 A01N59/20
To view Copptech’s complete patent history, request access »

Copptech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Copptech Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Apollo Global Management PE/Buyout Minority
Foresight Group Asset Manager Minority
Inter-American Development Bank Impact Investing Minority
IDB Lab Impact Investing Minority
Aurus Capital Venture Capital Minority
To view Copptech’s complete investors history, request access »

Copptech FAQs

  • When was Copptech founded?

    Copptech was founded in 2014.

  • Where is Copptech headquartered?

    Copptech is headquartered in London, United Kingdom.

  • What is the size of Copptech?

    Copptech has 17 total employees.

  • What industry is Copptech in?

    Copptech’s primary industry is Multi-line Chemicals.

  • Is Copptech a private or public company?

    Copptech is a Private company.

  • What is the current valuation of Copptech?

    The current valuation of Copptech is .

  • What is Copptech’s current revenue?

    The current revenue for Copptech is .

  • How much funding has Copptech raised over time?

    Copptech has raised $12.9M.

  • Who are Copptech’s investors?

    Apollo Global Management, Foresight Group, Inter-American Development Bank, IDB Lab, and Aurus Capital have invested in Copptech.

  • Who are Copptech’s competitors?

    BioCote, Microban International, Sanitized, HeiQ Materials, and Polygiene Group are competitors of Copptech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process